AU2022236293A1 - Proteins and uses thereof - Google Patents

Proteins and uses thereof Download PDF

Info

Publication number
AU2022236293A1
AU2022236293A1 AU2022236293A AU2022236293A AU2022236293A1 AU 2022236293 A1 AU2022236293 A1 AU 2022236293A1 AU 2022236293 A AU2022236293 A AU 2022236293A AU 2022236293 A AU2022236293 A AU 2022236293A AU 2022236293 A1 AU2022236293 A1 AU 2022236293A1
Authority
AU
Australia
Prior art keywords
seq
nos
protein
inflammatory
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022236293A
Other languages
English (en)
Other versions
AU2022236293A9 (en
Inventor
Paul Robert GIACOMIN
Alexander Constantine Loukas
Roland RUSCHER
Stephanie Margaret RYAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrobiome Therapeutics Pty Ltd
Original Assignee
James Cook University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2021900769A external-priority patent/AU2021900769A0/en
Application filed by James Cook University filed Critical James Cook University
Publication of AU2022236293A1 publication Critical patent/AU2022236293A1/en
Publication of AU2022236293A9 publication Critical patent/AU2022236293A9/en
Assigned to Macrobiome Therapeutics Pty Ltd reassignment Macrobiome Therapeutics Pty Ltd Request for Assignment Assignors: JAMES COOK UNIVERSITY
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2022236293A 2021-03-17 2022-03-17 Proteins and uses thereof Pending AU2022236293A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2021900769 2021-03-17
AU2021900769A AU2021900769A0 (en) 2021-03-17 Proteins and uses thereof
AU2022900508A AU2022900508A0 (en) 2022-03-03 Proteins and uses thereof (2)
AU2022900508 2022-03-03
PCT/AU2022/050234 WO2022192955A1 (en) 2021-03-17 2022-03-17 Proteins and uses thereof

Publications (2)

Publication Number Publication Date
AU2022236293A1 true AU2022236293A1 (en) 2023-09-21
AU2022236293A9 AU2022236293A9 (en) 2024-01-11

Family

ID=83321840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022236293A Pending AU2022236293A1 (en) 2021-03-17 2022-03-17 Proteins and uses thereof

Country Status (5)

Country Link
US (1) US20240174719A1 (enExample)
EP (1) EP4308592A4 (enExample)
JP (1) JP2024516079A (enExample)
AU (1) AU2022236293A1 (enExample)
WO (1) WO2022192955A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025170060A1 (ja) * 2024-02-08 2025-08-14 学校法人慈恵大学 急性肺障害治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303752B2 (en) * 2001-10-17 2007-12-04 The George Washington University Hookworm vaccine
GB0905511D0 (en) * 2009-03-31 2009-05-13 Moredun Res Inst Parasite detection
CN105745223A (zh) * 2013-09-18 2016-07-06 詹姆斯库克大学 修饰的抗炎蛋白及使用方法

Also Published As

Publication number Publication date
EP4308592A1 (en) 2024-01-24
EP4308592A4 (en) 2025-09-17
US20240174719A1 (en) 2024-05-30
JP2024516079A (ja) 2024-04-12
AU2022236293A9 (en) 2024-01-11
WO2022192955A1 (en) 2022-09-22

Similar Documents

Publication Publication Date Title
Dinarello The IL-1 family of cytokines and receptors in rheumatic diseases
US7304034B2 (en) Use of HMGB fragments as anti-inflammatory agents
CA2447576C (en) Use of hmg fragments as anti-inflammatory agents
US10981964B2 (en) Fusion protein comprising IL-4 and IL-10
Asaoka et al. Linear ubiquitination by LUBEL has a role in Drosophila heat stress response
JP2002505095A (ja) 喘息及び関連疾患を含むアトピー性アレルギーを治療するための標的としての喘息関連因子
KR20120120965A (ko) 자작나무 알레르기에 대한 펩티드백신
CN107454846B (zh) 修饰的肽及其治疗慢性炎性疾病的用途
US20240174719A1 (en) Proteins and uses thereof
JP2004518430A (ja) ストレスタンパク質およびペプチドならびにその使用方法
US20210309984A1 (en) ChiA Enzyme
US20200392185A1 (en) Compositions and methods of inhibiting the binding of plasma igg autoantibodies to serotonin 2a receptor
WO2024055378A1 (zh) 用于检测阿尔兹海默病自身抗体的蛋白抗原组合及其应用
US10738095B2 (en) Engineered CCL20 locked dimer polypeptide
US11571462B2 (en) Engineered CCL20 locked dimer polypeptide
WO2022120423A1 (en) Peptides and uses thereof
Kortum Comparative Analysis of Tripartite Motif Containing 9 Protein Expression in Macrophages and Neutrophils
CN114957434A (zh) 用于治疗自身免疫性疾病的多肽
Song Genome-wide Characterization of Heat Shock Proteins in Channel Catfish (Ictalurus punctatus) and Determination of Their Involvement in Diseases
AU2007234583A1 (en) Use of HMG fragment as anti-inflammatory agents
Pulsawat et al. http://eprints. gla. ac. uk/175376
PITKÄNEN Characterisation of the Autoimmune Regulator (AIRE) Protein
de Azevedo Domingues Role of TH1 and TH17 CD4+ T Cell Subsets in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Ye Modulation of innate immunity by nucleotide binding—biochemical and functional characterization of a CATERPILLER/NLR protein, Monarch-1/NLRP12

Legal Events

Date Code Title Description
SREP Specification republished
PC1 Assignment before grant (sect. 113)

Owner name: MACROBIOME THERAPEUTICS PTY LTD

Free format text: FORMER APPLICANT(S): JAMES COOK UNIVERSITY